Tag

Chronic Lymphocytic Leukemia Archives | Carevive - cancer care management & patient engagement tools

CME

Defining What is Value-Based Care for Patients with ​Relapsed/Refractory Chronic Lymphocytic Leukemia​

Defining What is Value-Based Care for Patients with ​Relapsed/Refractory Chronic Lymphocytic Leukemia​​ Release Date: July 6, 2018 Expiration Date:July 6, 2019 ESTIMATED TIME TO COMPLETE ACTIVITY: 150 minutes (2.5 hours)​     TARGET AUDIENCE The target audiences for these activities are hematologists, medical oncologists, pulmonologists, pathologists, physician assistants, nurse practitioners, registered nurses, oncology nurses, nurse navigators, palliative/symptom management teams who care for…
Carevive
July 6, 2018
CMEEvents

[Webinar] Defining What is Value-Based Care for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

Defining What is Value-Based Care for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: An Expert Roundtable Discussion Saturday, November 4, 2017 8:30 am – 12:05 pm CST UAB Comprehensive Cancer Center Birmingham, Alabama Do the requirements of OCM and other value-based cancer delivery models leave you overwhelmed about where and how to start? If so, then join us for a CME/CNE-Certified…
Carevive
October 17, 2017
CME

Evidence-Based Clinical Updates in the Treatment of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

Evidence-Based Clinical Updates in the Treatment of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia       For information about AMA PRA Category 2 CreditTM, you may consult page 10 of the AMA’s booklet “The Physicians Recognition Award and credit system: Information for accredited providers and physicians – 2010 Revision” found here. The aim of the project is to ensure hematology…
Carevive
June 14, 2017